Andrea H Weinberger1,2, Misato Gbedemah3,4, Melanie M Wall5,6, Deborah S Hasin6,7,8, Michael J Zvolensky9,10, Renee D Goodwin3,4,7. 1. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA. 2. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. 3. Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, The City University of New York, New York, NY, USA. 4. Institute for Implementation Science in Population Health, The City University of New York, New York, NY, USA. 5. Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA. 6. New York State Psychiatric Institute, New York, NY, USA. 7. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA. 8. Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA. 9. Department of Psychology, University of Houston, Houston, TX, USA. 10. Department of Behavioral Science, MD Anderson Cancer Center, Houston, TX, USA.
Abstract
BACKGROUND AND AIMS: While cigarette smoking has declined over time, it is not known whether this decline has occurred similarly among individuals with substance use disorders (SUDs) in the United States (US). The current study estimated trends in smoking from 2002 to 2014 among US individuals with and without SUDs. DESIGN: Linear time trends of current smoking prevalence were assessed using logistic regression models. SETTING: United States; data were drawn from the 2002 to 2014 National Household Survey on Drug Use (NSDUH), an annual US cross-sectional study. PARTICIPANTS: A representative, population-based sample of US individuals age 12 yeas and older (total analytical population: n = 723 283). MEASUREMENTS: Past-month current smoking was defined as having smoked at least 100 lifetime cigarettes and reporting smoking part or all of at least one cigarette during the past 30 days. Respondents were classified as having any SUD if they met criteria for abuse or dependence for one or more of the following illicit drugs: cannabis, hallucinogens, inhalants, tranquilizers, cocaine, heroin, pain relievers, simulants and sedatives. A second SUD variable included all drugs listed above excluding cannabis use disorder (CUD). An additional variable included respondents who met criteria for cannabis abuse or dependence. FINDINGS: Among those with any SUD, the prevalence of smoking did not change from 2002 to 2014 (P = 0.08). However, when CUDs were separated from other SUDs, a significant increase in prevalence of smoking was observed among those with SUDs excluding CUDs (P < 0.001), while smoking decreased among those with CUDs (P < 0.001). Smoking declined among those without SUDs (P < 0.001). In 2014, smoking remained significantly more common among those with any SUD (55.48%), SUDs excluding CUDs (63.34%) and CUDs (51.34%) compared with those without these respective disorders (18.16, 18.55 and 18.64%; P < 0.001). CONCLUSIONS: The prevalence of cigarette smoking in the United States increased from 2002 to 2014 among people with substance use disorders (SUDs) excluding cannabis use disorders (CUDs) and declined among those with CUDs and without SUDs. In 2014, the prevalence of smoking was multifold higher among those with SUDs, including CUDs, compared with those without SUDs.
BACKGROUND AND AIMS: While cigarette smoking has declined over time, it is not known whether this decline has occurred similarly among individuals with substance use disorders (SUDs) in the United States (US). The current study estimated trends in smoking from 2002 to 2014 among US individuals with and without SUDs. DESIGN: Linear time trends of current smoking prevalence were assessed using logistic regression models. SETTING: United States; data were drawn from the 2002 to 2014 National Household Survey on Drug Use (NSDUH), an annual US cross-sectional study. PARTICIPANTS: A representative, population-based sample of US individuals age 12 yeas and older (total analytical population: n = 723 283). MEASUREMENTS: Past-month current smoking was defined as having smoked at least 100 lifetime cigarettes and reporting smoking part or all of at least one cigarette during the past 30 days. Respondents were classified as having any SUD if they met criteria for abuse or dependence for one or more of the following illicit drugs: cannabis, hallucinogens, inhalants, tranquilizers, cocaine, heroin, pain relievers, simulants and sedatives. A second SUD variable included all drugs listed above excluding cannabis use disorder (CUD). An additional variable included respondents who met criteria for cannabis abuse or dependence. FINDINGS: Among those with any SUD, the prevalence of smoking did not change from 2002 to 2014 (P = 0.08). However, when CUDs were separated from other SUDs, a significant increase in prevalence of smoking was observed among those with SUDs excluding CUDs (P < 0.001), while smoking decreased among those with CUDs (P < 0.001). Smoking declined among those without SUDs (P < 0.001). In 2014, smoking remained significantly more common among those with any SUD (55.48%), SUDs excluding CUDs (63.34%) and CUDs (51.34%) compared with those without these respective disorders (18.16, 18.55 and 18.64%; P < 0.001). CONCLUSIONS: The prevalence of cigarette smoking in the United States increased from 2002 to 2014 among people with substance use disorders (SUDs) excluding cannabis use disorders (CUDs) and declined among those with CUDs and without SUDs. In 2014, the prevalence of smoking was multifold higher among those with SUDs, including CUDs, compared with those without SUDs.
Authors: Wilson M Compton; Beth Han; Christopher M Jones; Carlos Blanco; Arthur Hughes Journal: Lancet Psychiatry Date: 2016-08-31 Impact factor: 27.083
Authors: Damaris J Rohsenow; Jennifer W Tidey; Christopher W Kahler; Rosemarie A Martin; Suzanne M Colby; Alan D Sirota Journal: Addict Behav Date: 2014-12-10 Impact factor: 3.913
Authors: Teresa W Wang; Brandon Kenemer; Michael A Tynan; Tushar Singh; Brian King Journal: MMWR Morb Mortal Wkly Rep Date: 2016-12-09 Impact factor: 17.586
Authors: Andrea H Weinberger; Lauren R Pacek; Daniel Giovenco; Sandro Galea; Michael J Zvolensky; Misato Gbedemah; Renee D Goodwin Journal: Alcohol Clin Exp Res Date: 2018-12-10 Impact factor: 3.455
Authors: Siwen Xie; Haruka Minami; Danusha Selva Kumar; Jacki Hecht; Erika Litvin Bloom; Christopher Kahler; Ana Abrantes; Lawrence H Price; Steven Ondersma; Richard A Brown Journal: J Subst Use Date: 2020-09-28
Authors: Adria Zern; Michael Seserman; Heather Dacus; Barbara Wallace; Susan Friedlander; Marc W Manseau; Maxine M Smalling; Thomas E Smith; Jill M Williams; Michael T Compton Journal: Community Ment Health J Date: 2020-10-20